Bayer AG Phase III Trial Shows Effectiveness Of Fat-Reducing Drug-Reuters


Friday, 1 Feb 2013 05:43am EST 

Reuters reported that Bayer AG said results of two Phase III trials showed ATX-101, an injectable drug to reduce fat deposits under the chin, was effective as a non-surgical treatment. 

Company Quote

145.665
2.535 +1.77%
21 Nov 2014